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Nuclear receptors which interact with the retinoid X stratum corneum, whereas a distinct stratum corneum
and a thickened stratum granulosum were present inreceptor are involved in the regulation of epidermal
differentiation and development. We have recently treated pups. By electron microscopy, the extracellular
spaces of the stratum corneum in control pups revealedshown that activators of the peroxisome proliferator-
activated receptor and of the farnesoid X-activated a paucity of mature lamellar unit structures, whereas
these structures filled the stratum corneum intersticesreceptor accelerate epidermal barrier maturation in
fetal rat skin in vitro. In this study we asked whether in treated pups. Additionally, protein and mRNA levels
of loricrin and filaggrin, two structural proteins ofcutaneous development in utero was affected by
peroxisome proliferator-activated receptor or farne- stratum corneum, were increased in treated epidermis,
as were the activities of two lipid catabolic enzymessoid X-activated receptor activators, or by an activator
of another retinoid X receptor partner, liver X receptor. critical to stratum corneum function, b-glucocerebros-
idase and steroid sulfatase. Finally, peroxisome pro-Activators of the peroxisome proliferator-activated
receptor (clofibrate or linoleic acid), farnesoid X- liferator-activated receptor-a and -d and liver X
receptor-a and -b mRNAs were detected in fetalactivated receptor (farnesol or juvenile hormone III),
or liver X receptor (22R-hydroxycholesterol), were epidermis by reverse transcriptase–polymerase chain
reaction and northern analyses. The presence of theseinjected into the amniotic fluid of fetal rats on gesta-
tional day 17. Fetal epidermal barrier function and receptors and the ability of their activators to stimulate
epidermal barrier and stratum corneum developmentmorphology was assessed on day 19. Whereas vehicle-
treated fetal rats displayed no measurable barrier suggest a physiologic role for peroxisome proliferator-
activated receptor and liver X receptor and their(transepidermal water loss > 10 mg per cm2 per h), a
measurable barrier was induced by the intra-amniotic endogenous ligands in the regulation of cutaneous
development. Key words: farnesoid X-activated receptor/administration of all activators tested (transepidermal
water loss range 4.0–8.5 mg per cm2 per h). By liver X receptor/peroxisome proliferator activated receptor. J
Invest Dermatol 113:788–795, 1999light microscopy, control pups lacked a well-defined
T cellular lamellar membranes, contribute to the water-tight propertiesof the skin, whereas corneocyte proteins provide structural rigidityand cohesiveness, and provide a scaffold for membrane lipids(reviewed in Elias and Menon, 1991; Downing, 1992; Roop, 1995;Kalia et al, 1998). In mammals, a mature epidermis and competent
he outermost layer of the epidermis, the stratum
corneum (SC), provides the skin with a barrier to
water loss, necessary for terrestrial life. Lipids in the
extracellular spaces of the SC, predominantly fatty
acids, ceramides, and cholesterol, arranged into extra-
barrier are normally present prior to birth, whereas very premature
infants lack an adequate barrier, increasing their susceptibility to
hypothermia, fluid and electrolyte imbalance, and transcutaneouslyManuscript received January 19, 1999; revised May 28, 1999; accepted
acquired infections (Hammarlund and Sedin, 1979; Harpin andfor publication July 15, 1999.
Rutter, 1983; Cartlidge and Rutter, 1992).Reprint requests to: Dr. Karen Hanley, Dermatology Service (190),
Department of Veterans Affairs Medical Center, 4150 Clement St., San Epidermal barrier development in the fetal rat occurs over a
Francisco, CA 94121, U.S.A. short time period late in their 22 d gestation. Pups of gestational
Abbreviations: FXR, farnesoid X-activated receptor; JH III, juvenile age day 19 lack a measurable barrier to transepidermal water loss
hormone III; LXR, liver X receptor; PPAR, peroxisome proliferator- (TEWL), whereas a competent barrier is present by day 21
activated receptor; PPRE, peroxisome proliferator response element; SC, (Aszterbaum et al, 1992). The emergence of a functionally maturestratum corneum; TEWL, transepidermal water loss; 22R-OH Ch, 22R-
barrier correlates with the appearance of a multilayered SC andhydroxycholesterol.
with the formation of mature lamellar membranes in the SC1The authors did not submit a completed declaration of conflict of
interest form as requested by JID’s ‘‘Information for authors’’. interstices (Aszterbaum et al, 1992). Furthermore, the expression
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of structural proteins, such as loricrin, filaggrin, and involucrin,
necessary for corneocyte formation, increase during barrier matura-
tion (Bickenbach et al, 1995; Ko¨mu¨ves et al, 1998). Finally, the
activities of lipid enzymes important for normal SC function,
such as β-glucocerebrosidase, which converts glucosylceramide to
ceramide, and steroid sulfatase, which catalyzes the desulfation of
cholesterol sulfate, also increase during barrier maturation (Hanley
et al, 1997a, b).
Hormones such as glucocorticoids, estrogens, and androgens,
which exert effects on transcriptional events in a wide variety of
tissues via their respective nuclear steroid hormone receptors,
regulate fetal SC formation in vitro and barrier development in vivo
when administered to the mother (Aszterbaum et al, 1993; Hanley
et al, 1996a). Additionally, fetal mice made deficient in either
glucocorticoids or thyroid hormone exhibit delayed epidermal and
SC maturation (Hanley et al, 1997c, 1998c). These hormones do
not appear to be essential, however, because: (i) a mature SC is
present at birth in glucocorticoid-deficient or hypothyroid mice
(Hanley et al, 1997c, 1998c), and (ii) the timetable of epidermal
development proceeds normally in skin explants taken from fetal
rats of gestational day 17 and incubated in hormone- and serum-
free media (Hanley et al, 1996b). Taken together, these findings
suggest that endogenous skin-derived factors, rather than factors
Figure 1. Fetal epidermal barrier function is improved by treatmentdelivered systemically, may be important mediators of epidermal
with activators of PPAR, FXR, or LXR. Vehicle (veh) (DMSO),and SC development.
clofibrate (clof), linoleic acid (LA), farnesol (farn), juvenile hormone IIIIn searching for putative locally generated regulators of SC
(JH), or 22R-OH Ch (22R) were injected intra-amniotically on gestationaldevelopment, we have considered the retinoid X receptor (RXR)
day 17, and TEWL measured in fetal rat epidermis on gestational day 19,subfamily of nuclear receptors. RXR forms heterodimers with as described in Materials and Methods. Results are expressed as the
other ligand-activated receptors, such as RAR, the vitamin D mean 6 SEM, n 5 8; *p , 0.01; **p , 0.05. Each data point represents
receptor, and the thyroid hormone receptor, whose ligands are the average of two experiments (eight fetuses) for each treatment.
known to exert potent effects on growth and differentiation of
skin and other tissues (Mangelsdorf and Evans, 1995; Kang et al,
1996). Other members of the RXR-heterodimerizing family Sigma (St. Louis, MO), was injected into the amniotic fluid space of
include: (i) peroxisome proliferator-activated receptor (PPAR), individual amniotic sacs. Pregnant animals were immediately closed, and
involved in fatty acid metabolism in tissues such as liver and kidney, the pregnancy was allowed to proceed for an additional 48 h. Separate
for which an array of fibrates, eicosanoids, and fatty acids have maternal animals were used for each treatment group to avoid possible
neighbor effects, or effects on littermates in the opposite uterine horn.recently been identified as ligands (Keller et al, 1993; Gottlicher
Fetal animals were removed prematurely on day 19 by cesarean section.et al, 1992; Yu et al, 1995; Schoonjans et al, 1996); (ii) farnesoid
For sham-operated controls, maternal animals were anesthetized andX-activated receptor (FXR), a relative of the ecdysone receptor,
surgically opened as above, but were immediately closed, with no injec-which regulates development in insects, is activated by juvenile
tions made.hormone III (JH III) and farnesol, an intermediate in the cholesterol
biosynthetic pathway (Forman et al, 1995); and (iii) liver X receptor TEWL This was measured in fetal animals on day 19 using a Meeco
(LXR), which regulates bile acid synthesis in the liver and is electrolytic water analyzer as described previously (Aszterbaum et al, 1992).
activated by oxidized sterols (Willy et al, 1995; Lehmann et al,
1997). We have shown previously that PPAR and FXR activators Light and electron microscopy Samples of fetal skin from the lower
accelerate barrier formation in fetal skin explants (Hanley et al, anterior abdominal wall were fixed in modified Karnovsky’s fixative, Epon-
1998a). Furthermore, we have shown that PPAR activators induce embedded and 0.5 µm sections were stained with hematoxylin/eosin for
light microscopy, as described previously (Hanley et al, 1996b). Parallelkeratinocyte differentiation in vitro (Hanley et al, 1998b). Thus,
samples for electron microscopy were minced to 1 mm3 fragments, fixedputative products of epidermal metabolism, including some free
in modified Karnovsky’s fixative and postfixed in reduced 1% osmium orfatty acids, an intermediate in the cholesterol biosynthetic pathway,
buffered 0.2% ruthenium tetroxide with 0.5% ferrocyanide (Aszterbaumand oxidative products of cholesterol, which activate nuclear
et al, 1992). Samples were then dehydrated in graded ethanol, embeddedreceptors in the RXR family, may regulate epidermal differentiation in Epon, and sectioned. Samples were examined in a Zeiss electron
and development. microscope at 60 kV. Pictures shown for both light and electron microscopy
In this study we sought to determine whether activators of are representative of the changes observed in samples obtained from at
PPAR, FXR, and LXR regulate epidermal development in vivo. We least two different litters for each treatment.
show here that intra-amniotic administration of PPAR activators,
clofibrate and linoleic acid, FXR activators, farnesol and JH III, In situ hybridization Digoxigenin-labeled RNA probes to detect loric-
rin and filaggrin were made from linearized cDNA sequences as templates,and 22R-hydroxycholesterol (22R-OH Ch), an LXR activator,
using reagents purchased from Boehringer-Mannheim (Indianapolis, IN),accelerates the maturation of the SC and epidermal barrier in
as described previously (Ko¨mu¨ves et al, 1998). In situ hybridization wasfetal rats.
performed on sections of paraffin-embedded tissue as described (Stelnicki
et al, 1998), with minor modifications. Briefly, probes were applied to theMATERIALS AND METHODS
sections and hybridized at 55°C for loricrin or 40°C for filaggrin/
profilaggrin. Washing and blocking was performed as described (StelnickiAnimal treatments Timed-pregnant Sprague–Dawley rats (plug date 5
et al, 1998).day 0) were obtained from Simonsen Laboratories (Gilroy, CA). On day
17 of gestation, maternal animals were anesthetized with forane and a
ventral midline incision was made. The uterine horns were exposed and Protein detection by immunohistochemistry Immunohistochemistry
kept moist with warm saline, and 50 µl of either saline, clofibrate (2-(p- was performed as described previously (Ko¨mu¨ves et al, 1998). Loricrin was
chlorophenoxy)-2-methyl-propionic acid ethyl ester) (1.0 mg), linoleic detected with a rabbit anti-peptide antibody, specific for mouse loricrin,
acid (1.0 mg), farnesol (0.75 mg), juvenile hormone III (JH III) (1.0 mg), and a rabbit antibody specific for rat filaggrin was used to localize filaggrin/
profilaggrin antibody (both antibodies were from BabCo, Berkeley, CA).22R-OH Ch (0.75 mg), or vehicle [dimethylsulfoxide (DMSO)], all from
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Figure 2. Epidermal development is accelerated
by PPAR, FXR, and LXR activators. Animals
were treated as described in the legend to Fig 1 and
epidermal samples from gestational age day 19 fetal
rats were immediately processed as described in
Materials and Methods. Paraffin-embedded sections
were stained with hematoxylin–eosin. (A) DMSO
vehicle; (B) clofibrate; (C) farnesol; (D) 22R-OH
Ch. Scale bar: 10 µm.
Figure 3. The appearance of mature lamellar
membranes in the SC is accelerated by PPAR
activators. Parallel samples were taken from animals
as described in Fig 2, and postfixed in ruthenium
tetroxide. The extracellular spaces of the SC in
epidermis from clofibrate (CLOF) -treated pups
exhibit mature lamellar membranes (closed arrows).
Inset: the SC interstices in DMSO vehicle (VEH)-
treated epidermis are filled predominantly with
material not yet fully processed (open arrow). Scale
bar: 0.2 µm.
Enzyme assays Epidermis was isolated from whole skin and β-glucocere- transcriptase-for-PCR kit, Clontech, San Diego, CA) at 42°C for 2 h. As
a control experiment, cDNA synthesis reactions were carried out withoutbrosidase activity was measured as described previously (Hanley et al,
1997a). Briefly, epidermis from day 19 fetal rats was homogenized in reverse transcriptase for every RNA sample to evaluate DNA contamin-
ation. The PCR mixture (50 µl) contained 0.4 µM final concentration ofphosphate-buffered saline containing 0.1 mM phenylmethylsulfonyl
fluoride and 0.1% Tween 20, incubated 30 min on ice, and centrifuged at each (forward and reverse) primer, 0.2 mM of each deoxynucleotide
triphosphate, and 1 3 Taq DNA polymerase in PCR buffer (all from10 000 3 g for 10 min (4°C). Fifty microliters of the resultant supernatant
was added to an equal volume of reaction buffer (5 mM sodium taurocholate Clontech). FXR-specific cDNA products were amplified by PCR with
the following oligonucleotides: forward primer: 59 cgt gac ttg cgn caa gtgwith 0.5 mM 4-methylumbelliferyl-β-D-glucopyranoside in citrate phos-
phate buffer, pH 5.6) and incubated 60 min at 37°C. The reaction was acc 39, reverse: 59 cca nga cat cag cat ctc agc g 39 (primer set 1), designed
to yield a 683 bp product; forward: 59 ctg acc caa aac aat cc 39, reverse:terminated with 2 ml of pH 10.5 carbonate-bicarbonate buffer, and
fluorescence was measured at 360 λ (emission) and 450 λ (excitation). 59 ccc ctt tta ttc ttc cc 39 (primer set 2), for a product size of 448 bp.
Samples were heated to 97°C for 5 min, followed by 35 cycles ofSteroid sulfatase was assayed in epidermal microsomal preparations as
previously described (Hanley et al, 1997b). Assays were performed in denaturation at 97°C for 1 min, annealing at 68°C (primer set 1) or 56°C
(primer set 2) for 1 min, and extension at 72°C for 1 min, with a final0.1 M Tris–HCl, pH 7.4, with 5.6 mM glucose and 15 µM (5 µCi)
[3H]dehydroepiandrosterone sulfate for 2 h at 37°C. Following extraction extension at 72°C for 5 min, using a Perkin-Elmer Thermal Cycler (Model
480). PCR products were separated by electrophoresis on a 1.5% agarosewith benzene, product ([3H]dehydroepiandrosterone) was quantitated by
scintillation spectroscopy. gel and visualized with ethidium bromide staining. A 1Kb DNA ladder
(Promega, Madison, WI) was used for molecular weight markers. The
identity of the amplified PCR product was confirmed as an FXR cDNAReverse transcriptase–polymerase chain reaction (PCR) Full-thick-
ness skin was excised from day 17 fetal rats and floated dermis side down by southern analysis using a [32P]-labeled FXR cDNA (a gift from Dr S.
Jackson, UCLA).on 10 mM ethylenediamine tetraacetic acid in calcium- and magnesium-
free phosphate-buffered saline, pH 7.4, at 37°C for 45 min. Epidermis was PPAR-specific cDNA products were amplified by PCR using oligo-
nucleotides derived from published cDNA sequences. For rat PPARα theisolated as a sheet, snap-frozen, and stored at –70°C. Total RNA was
isolated using Trizol (Sigma) following manufacturer’s instructions. Total down primer was 59-tct gta gat ctc ttg caa cag-39 and the up primer was
59-gcc agt gca tgt ccg tgg aga-39, spanning 568 bp in the ligand-bindingRNA (0.8 µg) was reverse transcribed with 20 ng random hexamer (reverse
VOL. 113, NO. 5 NOVEMBER 1999 ACCELERATED EPIDERMAL MATURATION 791
were then performed in a solution containing 0.1% sodium citrate/chloride
buffer and 0.1% sodium dodecyl sulfate for 30 min at room temperature,
followed by a 30 min wash at 65°C. Autoradiography was performed at
–70°C. Molecular biology-grade reagents were obtained from Sigma or
from Pharmacia Biotech (Uppsala, Sweden).
Statistics Statistical analysis was performed using a Student’s t test.
RESULTS AND DISCUSSION
Surgical and vehicle controls Surgery accelerates fetal lung
development in several species, perhaps due to an increase in
cortisol levels (Hitchcock, 1979). We have shown previously that
glucocorticoids accelerate epidermal barrier development in rats
(Aszterbaum et al, 1993); therefore, we first determined if surgical
stress alone affected the maturation of the epidermal barrier. TEWL
was measured on gestational day 19 in animals from mothers who
had undergone sham surgical procedures on day 17 but were
otherwise untreated, and in control untreated day 19 fetal animals.
TEWL was . 10 mg per cm2 per h (off-scale) in both groups of
animals, as previously reported for 19 d fetal rat pups (Aszterbaum
et al, 1992). The morphology of the epidermis, examined by light
and electron microscopy, was also unaffected by sham surgery (data
not shown). We also compared epidermal function and morphology
in sham-operated, noninjected control animals to animals injected
intra-amniotically with 50 µl of saline or DMSO. We found no
effect of either vehicle on epidermal barrier function or morphology
(data not shown). Thus, neither surgery alone, nor the intra-
amniotic administration of saline or DMSO, alters epidermal
development.
Nuclear hormone receptor activators accelerate barrier
formation To determine whether treatment with activators of
PPAR, FXR, or LXR accelerates epidermal barrier formation, we
initially measured epidermal barrier function in animals injected
intra-amniotically with either clofibrate, linoleic acid, farnesol, JH
III, 22R-OH Ch, or DMSO (vehicle). As shown in Fig 1, vehicle-
treated fetal rats on day 19 exhibit no measurable barrier to water
loss (. 10 mg per cm2 per h, off-scale). For statistical purposes,
off-scale readings were recorded as 10.00 mg per cm2 per h. In
contrast, intra-amniotic administration of the PPAR activators,
clofibrate or linoleic acid, on day 17, resulted in decreased rates of
TEWL on day 19. TEWL was reduced by approximately 50% in
treated pups compared with vehicle-treated animals: clofibrate
5.60 6 0.80 mg per cm2 per h; linoleic acid 6.60 6 1.0 mg per
Figure 4. Activities of β-glucocerebrosidase (A) and steroid sulfatase (B) cm2 per h, n 5 8 (two litters each treatment). Administration of
are increased in epidermis from clofibrate (clof), farnesol (farn), or 22R- FXR or LXR activators into the amniotic fluid also accelerated
OH Ch (22R) -treated pups compared with vehicle (DMSO) -treated the maturation of epidermal barrier function (Fig 1): farnesol-
controls (con). Enzyme activity was measured in epidermis taken from treated 6.10 6 0.80 mg per cm2 per h; JH III-treated 4.00 6 1.10 mgfetal rats of gestational age day 19 as described in Materials and Methods. per cm2 per h; 22R-OH Ch-treated 8.5 6 0.4 mg per cm2 per h,Results are expressed as the mean 6 SEM *p , 0.01, **p , 0.05; n 5 5.
n 5 8 (resulting from two litters each treatment). These data
indicate that activators of PPAR, FXR, or LXR decrease trans-
epidermal water movement in intact animals.domain (Goettlicher et al, 1992). For rat PPARδ, down primer 59-cat cac
agc cca tct gca gct ggt-39, and up primer 59-gtc atg gaa cag cca cag gag We next determined whether the appearance of morphologic
gag-39 were used to span a 191 bp sequence within the A/B domain (Xing correlates of barrier maturity were also accelerated by clofibrate,
et al, 1995). For PPARγ, primers derived from the mouse PPARγ cDNA farnesol, or 22R-OH Ch. By light microscopy, control pups
sequence were used as described (Braissant et al, 1996): down 59-tat cat displayed a thin, distinct SC but lacked a well-defined SC (Fig 2A).
aaa taa gct tca atc gga tgg ttc-39; up: 59-gag atg cca ttc tgg ccc acc aac ttc The epidermis from pups treated with clofibrate, farnesol, or 22R-
gg-39, spanning 420 bp in the A/B and C domains. Samples were heated OH Ch exhibited a thickened SC and a distinct, multilayered SCto 95°C for 5 min, followed by 32 cycles at 95°C for 1 min, 59°C for
(Fig 2B–D, respectively). Electron microscopy revealed that the1 min, and 72°C for 1.5 min with a final extension step at 72°C for
majority of the lipid material in the SC interstices of control animals10 min. PPAR PCR products were separated by electrophoresis on a 1.5%
(Fig 3, VEH) was not yet organized into mature lamellar unitagarose gel containing ethidium bromide, using a 100 bp DNA ladder
(Gibco, Grand Island, NY) to determine the size of the PCR products. structures; localized areas of lamellar unit structures were present
in the extracellular spaces of the SC in some of the control animals
Northern blotting Poly(A)1 mRNA was isolated from day 17 rat (data not shown) whereas others completely lacked mature lamellae
epidermis as previously described (Hanley et al, 1997a, b). Eight micrograms (Fig 3, VEH). In contrast, the SC interstices in epidermis from
per sample was size fractionated through a 1% agarose gel containing 2.2 M clofibrate-treated fetal rats (Fig 3, CLOF) were filled with mature
formaldehyde, as described previously (Hanley et al, 1997a, b). RNA lamellar unit structures. Similar results were observed followingintegrity was visualized following Acridine orange staining of the electro-
treatment with linoleic acid, JH III, farnesol, and 22R-OHChphoresed gel. The RNA was transferred to a nylon membrane which was
(data not shown). Thus, intra-amniotic administration of PPAR,subsequently baked at 80°C for 2 h. Blots were hybridized with [32P]-
FXR, or LXR activators accelerates both the functional and thelabeled LXRα and LXRβ cDNAs (kindly provided by Dr D. Mangelsdorf
(SW University, Dallas, TX) or FXR cDNA overnight at 65°C. Washes morphologic maturation of the fetal epidermal permeability barrier.
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Figure 5. mRNA levels of profilaggrin and
loricrin are increased in epidermis from treated
fetal rats. Loricrin and profilaggrin mRNA was
detected in fetal rat epidermis by in situ hybridization,
as described in Materials and Methods. Increased staining
is evident in the epidermis taken from treated pups
(C, D, clofibrate; E, F, farnesol; and G, H, 22R-OH
Ch) compared to vehicle (DMSO) -treated (A, B).
Scale bar: 0.5 µm.
Increased SC lipid enzyme activity and expression of struc- increases in the expression of profilaggrin and loricrin mRNA in
the upper epidermis [Fig 5: controls (A, B); PPAR activators (C,tural proteins by nuclear receptor activators Previous studies
have shown that the lipid metabolizing enzymes β-glucocerebrosid- D); FXR activators (E, F); LXR activators (G, H)]. Moreover, as
shown in Fig 6, protein levels of profilaggrin/filaggrin and loricrinase and steroid sulfatase increase during SC and epidermal barrier
development (Hanley et al, 1997a, b). β-glucocerebrosidase catalyzes are also increased by treatment with clofibrate, farnesol, or 22R-
OH Ch. Thus, the expression of proteins required for the formationthe conversion of glucosylceramides to ceramides in the SC
interstices. Ceramides are required for the formation of normal of the cornified envelope and keratohyalin granules are also
stimulated by nuclear hormone receptor activators, resulting inlamellar membranes and for normal barrier function, and inhibition
of β-glucocerebrosidase activity results in an abnormal permeability accelerated but apparently normal epidermal development, and
barrier (Holleran et al, 1993). Steroid sulfatase catalyzes the conver- suggesting that there is a co-ordinate regulation of both the
sion of cholesterol sulfate to cholesterol, a reaction essential for lipid and protein components required for epidermal and SC
normal SC desquamation (Epstein et al, 1981). Additionally, recent development.
studies have shown that the impaired conversion of cholesterol During normal epidermal development, co-ordinate regulation
sulfate to cholesterol also results in an abnormal permeability barrier of the lipid and protein components of the SC has been demon-
(Zettersten et al, 1998). As shown in Fig 4(A, B), the activity strated both in vivo and in vitro (Bickenbach et al, 1996; Ko¨mu¨ves
of β-glucocerebrosidase and steroid sulfatase are modestly but et al, 1998). Similarly, in this study, nuclear hormone receptor
significantly increased in pups treated with PPAR, FXR, or LXR activators coordinately stimulated both lipid and protein elements
activators. These data indicate that nuclear hormone receptor essential for normal epidermal and SC development. Coordinate
activators stimulate the activity of key lipid catabolizing enzymes regulation is not invariably observed, however. In intrauterine
that are required for normal SC function. growth-retarded fetal rats, the expression of cornification markers
Profilaggrin and loricrin are structural protein markers of late is decreased whereas the formation of the permeability barrier
epidermal development. Both are key constituents of keratohyalin proceeds normally (Hoath et al, 1990; Williams et al, 1993).
granules (Dale et al, 1985; Bickenbach et al, 1995). Subsequently, Moreover, in mice overexpressing a retinoic acid receptor dominant
loricrin is cross-linked into the cornified envelope, whereas filaggrin negative mutant in the suprabasal epidermis, corneocyte formation
participates in keratin filament assembly and is required for corneo- proceeds normally whereas the development of the extracellular
cyte hydration (Fuchs, 1990; Steven et al, 1990). Here we examined lipid lamellae in the SC is impaired (Imakado et al, 1995).
the expression of profilaggrin and loricrin mRNA by in situ
Expression of nuclear hormone receptors in fetal epidermishybridization. In comparison with vehicle-treated animals, animals
treated with nuclear hormone receptor activators displayed striking To determine whether PPAR, LXR, or FXR activators could be
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Figure 6. Protein levels of profilaggrin/filaggrin
and loricrin are increased in epidermis from
treated fetal rats. Filaggrin and loricrin proteins
were detected in fetal rat epidermis by
immunocytochemistry as described in Materials and
Methods. Increased staining is evident in the epidermis
taken from treated pups (C, D, clofibrate; E, F,
farnesol; and G, H, 22R-OH Ch) compared to
vehicle (DMSO) -treated (A, B). Scale bar: 0.5 µm.
acting via their respective receptors, we next sought evidence that strated using a variety of techniques. It remains possible that there
is an unrecognized nuclear hormone receptor closely related tothese receptors are expressed in fetal epidermis. Similar to recent
findings by others (Braissant and Wahli, 1998), PPAR isoforms α FXR that is present in the skin and activated by farnesol and JH
III. Alternatively, it is possible that farnesol and JH III activateand δ, but not γ, were detected by reverse transcriptase–PCR in
epidermis from rats of gestational age day 17 (Fig 7A). The PPAR. Indeed, recent studies by our laboratory have shown that
farnesol and JH III increase the expression of a PPRE transfectedpresence of PPARα was confirmed by northern analysis (data not
shown). LXRα and LXRβ were detected in day 17 epidermis by into keratinocytes (unpublished observations). Similar observations
have been reported by O’Brien et al (1996) who demonstrated thatnorthern analysis as transcripts of approximately 1.9 and 2.0 kb,
respectively (Fig 7B). In contrast, FXR mRNA was not detected farnesol and farnesoic acid increase PPRE expression in CV-1 cells.
Thus, it is possible that farnesol and JH III stimulate epidermal andin day 17 epidermis by northern analysis (data not shown) or by
reverse transcriptase–PCR (Fig 7C, lanes 1 and 2) (see Materials SC development by activating PPARα or PPARδ. Finally, these
compounds could exert their effects via non-nuclear receptorand Methods, primer set 1) (liver and kidney, Fig 7C, lanes 4 and
5, are shown as positive controls) or using an alternate set of mediated pathways.
Previous studies have shown that fetal epidermis is an activeprimers (see Materials and Methods, primer set 2) (not shown).
Southern blot analysis using an FXR cDNA probe confirmed the site of both cholesterol and fatty acid synthesis, with synthetic
rates high on gestational day 17 and declining with epidermalPCR product from rat liver and kidney as FXR mRNA; no signal
was detected in lanes containing epidermis (not shown). Similarly, differentiation and the maturation of the SC (Hurt et al, 1995).
Thus, endogenous fatty acids, intermediates in the cholesterolFXR mRNA was not detected in full-thickness skin from day 17
rats (Fig 7C, lane 3). These data indicate that PPARα and PPARδ synthetic pathway, and oxidation products of cholesterol, are all
likely to be present in fetal epidermis early in development, andand LXRα and LXRβ mRNAs are present in fetal epidermis, but
that FXR is not present in epidermis or dermis on gestational day could serve as activators of nuclear hormone receptors, thereby
locally regulating epidermal and SC development. We have17. These data are consistent with the hypothesis that clofibrate and
linoleic acid could be stimulating epidermal and SC development by previously shown that epidermal maturation and SC formation
proceeds normally in skin explants incubated in hormone- andactivating PPARα or PPARδ, or both; and that 22R-OH Ch
could be stimulating development by activating LXRα or LXRβ serum-free media, suggesting that locally derived factors may be
important mediators of epidermal and SC development (Hanleyor both. In contrast, farnesol and JH III cannot be stimulating
barrier ontogenesis via FXR, because FXR could not be demon- et al, 1996b). Endogenous activation of nuclear hormone receptors
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